Programs for PRO Educational Initiative are Announced
PITTSBURGH, Jan. 29 /PRNewswire/ -- invivodata inc., the industry leader in electronic patient reported outcomes (ePRO) solutions and services for global clinical research, today officially opened registration for ePROficiency(TM) 2009 -- its annual Patient Reported Outcomes Conference. Pharmaceutical research professionals can visit http://www.invivodata.com/epro2009 to register for the educational conference, which is being held April 21 - April 23, 2009 in Naples, Florida.
Gathering scientists, technologists, and regulatory experts, this annual conference produces interactive discussions on PRO regulatory guidelines and best practices for designing and executing ePRO systems in clinical research. This year's agenda includes speakers from regulatory agencies and top pharmaceutical companies, including Bristol-Myers Squibb, Cypress Bioscience, Grunenthal, and Hoffmann-La Roche. Attendees can participate in presentations and case studies on topics ranging from the successful development of a PRO strategy to eDiary supported Food and Drug Administration (FDA) submissions.
Representatives from 30 international biopharmaceutical companies attended last year's conference to engage in discussions about the advancing role of ePRO in new drug development. A senior director of clinical science at Takeda(C) Pharmaceuticals who attended last year's event remarked, "Don't think about embarking on an ePRO strategy for your drug development without attending this conference -- a must attend event."
ePROficiency is the cornerstone of invivodata's ongoing educational initiative which is designed to benefit all clinical researchers interested in ePRO, regardless of their experience or knowledge of the current PRO environment. invivodata offers a variety of programs that focus on recent re
'/>"/>
| SOURCE invivodata inc. Copyright©2009 PR Newswire. All rights reserved |